XTL BIOPHARMACEUTICALS LTD. Basic And Diluted Earnings Loss Per Share From Discontinued Operations
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Basic And Diluted Earnings Loss Per Share From Discontinued Operations of -$0.00 per share for the 12-month period ending 2015-12-31, per its 20-F filed 2018-03-15.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:BasicAndDilutedEarningsLossPerShareFromDiscontinuedOperations · last filed 2018-03-15
| Period end | Basic And Diluted Earnings Loss Per Share From Discontinued Operations 12 month |
|---|---|
| 2015-12-31 | -$0.00 20-F · filed 2018-03-15 |